Back to Agenda
CDER Town Hall (Part 1 of 2)
Session Chair(s)
Nancy D. Smith, PhD
Adjunct Professor
Temple University, FDA Alumni, United States
This forum is a roundtable discussion with CDER leadership. It will include discussion and updates on regulatory changes; hot topics at CDER will be discussed, and the audience will be invited to submit questions of general interest.
Part 2 will take place on Thursday at 10:45 am (Session #426).
Please come prepared with your questions for the CDER Town Hall panel. You may submit questions and topics of interest in advance to annualmeetingprogram@diahome.org, and include “CDER Town Hall” in the subject line.
Learning Objective : Summarize key issues discussed by CDER; Identify regulatory hot topics.
Speaker(s)
Panelist
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Panelist
John Jenkins
John K. Jenkins Advisors, LLC, United States
Principal
Panelist
Sandra Kweder, MD
Greenleaf Health/Elilquent, United States
Principal, Drug and Biological Products
Panelist
Justina Molzon, JD, MS
Consumer Services, United States
Consumer Services
Panelist
Christine Moore, PhD
Organon & Co., United States
Executive Director, Global External Advocacy and Standards
Have an account?